Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

9.50p
   
  • Change Today:
    -0.25p
  • 52 Week High: 87.50
  • 52 Week Low: 9.50
  • Currency: UK Pounds
  • Shares Issued: 165.93m
  • Volume: 66,417
  • Market Cap: £15.76m
  • RiskGrade: 348
  • Beta: 0.02

RENX Overview

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1244.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.1 n/a
Pr/Book 1.1  
Latest F'cast
Revenue 14.6% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

RENX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 n/a (7.12) (17.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-20 n/a (10.61) (16.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-21 1.49 (35.79) (43.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-22 2.97 (49.63) (78.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-23 3.40 (46.22) (56.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

RENX Company Announcements

Change of Adviser 30-Aug-2024 07:00 RNS
Total Voting Rights 30-Aug-2024 07:00 RNS
Nasdaq Grants Listing Extension 27-Aug-2024 09:30 RNS

RENX ShareCast News

Renalytix terminates formal sale process 20-Aug-2024 ShareCast
Renalytix test gets US Medicare coverage determi... 14-Jun-2024 ShareCast
Renalytix surges on takeover approach 04-Mar-2024 ShareCast

Latest RENX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

RENX Market Data

Currency UK Pounds
Share Price 9.50p
Change Today -0.25p
% Change -2.56 %
52 Week High 87.50
52 Week Low 9.50
Volume 66,417
Shares Issued 165.93m
Market Cap £15.76m
Beta 0.02
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.46% above the market average14.46% above the market average14.46% above the market average14.46% above the market average14.46% above the market average
65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average
Price Trend
94.76% below the market average94.76% below the market average94.76% below the market average94.76% below the market average94.76% below the market average
94.59% below the sector average94.59% below the sector average94.59% below the sector average94.59% below the sector average94.59% below the sector average
Income Not Available
Growth
26.42% above the market average26.42% above the market average26.42% above the market average26.42% above the market average26.42% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

RENX Dividends

No dividends found

Trades for 13-Sep-2024

Time Volume / Share Price
16:09 2,000 @ 9.50p
16:08 7,416 @ 9.51p
15:21 105 @ 10.00p
15:11 5,006 @ 9.75p
10:24 25,000 @ 9.51p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page